News

Parr Brown Gee & Loveless is pleased to announce that Kade Olsen and Michael Wilde have been promoted to shareholders. Kade Olsen is a member of the Firm’s Commercial Litigation group, where his practice focuses on complex commercial litigation and defending against class actions. His experience includes resolving matters related to false advertising, trademarks, trade secrets, consumer privacy, restrictive covenants and more, across various industries. He received his J.D., magna cum laude, from New York University School of Law. Michael Wilde is a member of Parr Brown’s Commercial Litigation group. He specializes in complex insurance coverage litigation for both companies

Parr Brown represented the Gardner Group as transaction counsel in a $460 million platform partnership with rPlus Energies, for a 15 GW pipeline of solar, wind, battery, and pumped storage hydropower projects. The team of Parr Brown attorneys includes shareholders Lamont Richardson, Kenneth Tillou, and Seth King. Sandbrook Capital Commits $460M to rPlus Energies

Exterior photo of Parr Brown Logo on upper side of glass building set against blue sky

Parr Brown Gee & Loveless today announced that shareholder Jonathan O. Hafen, the Court-appointed Receiver in the Rust Rare Coin Ponzi scheme, has made three initial distributions to victims totaling $23,273,521.88. For well over a decade, Gaylen Rust defrauded hundreds of victims by falsely claiming that he was operating a lucrative silver bullion trading program. Rust used the highly regarded Salt Lake City coin shop started by his father as a front for the fraud. Rust told prospective investors that all of the silver trades were conducted through a Rust Rare Coin account at HSBC Bank and that profits generated

Utah law firm Parr Brown Gee & Loveless attorneys

Parr Brown Gee & Loveless recently advised Merit Medical Systems Inc. in connection with its Rule 144A offering of $747.5 million in aggregate principal amount of its 3.00% senior notes due 2029 and the capped call transactions entered by Merit in connection with the offering. Merit intends to use the net proceeds from the offering to pay the cost of the capped call transactions and for general corporate purposes. Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit